Try our beta test site
101 studies found for:    Medivation
Show Display Options
Rank Status Study
21 Active, not recruiting A Phase 1 Study of MDV3100 in Patients With Castration-Resistant (Hormone-Refractory) Prostate Cancer
Conditions: Prostate Cancer;   Hormone Refractory Prostate Cancer
Intervention: Drug: MDV3100
22 Withdrawn Efficacy and Safety Study of MDV9300 in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Conditions: Lymphoma, Large B-Cell, Diffuse;   Primary Mediastinal Large B-cell Lymphoma;   Transformed Indolent Lymphoma
Intervention: Biological: MDV9300
23 Active, not recruiting A Phase 2, 2-Stage, 2-Cohort Study of Talazoparib (BMN 673), in Locally Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (ABRAZO Study)
Conditions: Breast Neoplasms;   BRCA 1 Gene Mutation;   BRCA 2 Gene Mutation
Intervention: Drug: talazoparib
24 Active, not recruiting Safety Study of Continued Enzalutamide Treatment In Prostate Cancer Patients
Condition: Prostate Cancer
Interventions: Drug: Enzalutamide;   Drug: Abiraterone;   Drug: Placebo for Enzalutamide;   Drug: Prednisone
25 Completed Study of BMN 673, a PARP Inhibitor, in Healthy Adult Male Volunteers
Condition: Human Volunteers
Intervention: Drug: BMN 673
26 Completed
Has Results
Study of Enzalutamide (Formerly MDV3100) as a Neoadjuvant Therapy for Patients Undergoing Prostatectomy for Localized Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Enzalutamide;   Drug: Leuprolide;   Drug: Dutasteride
27 Completed Safety, Tolerability and Efficacy Study of the Monoclonal Antibody, CT-011, in Patients With Metastatic Melanoma
Conditions: Melanoma;   Malignant Melanoma
Intervention: Drug: CT-011
28 Terminated Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies
Conditions: Acute Myeloid Leukemia;   Myelodysplastic Syndrome;   Chronic Lymphocytic Leukemia;   Mantle Cell Lymphoma
Intervention: Drug: BMN 673
29 Active, not recruiting
Has Results
A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Enzalutamide;   Drug: Placebo
30 Terminated An Extension of the CONCERT Protocol (DIM18)
Condition: Alzheimer's Disease
Intervention: Drug: Dimebon
31 Completed
Has Results
Determine the Effect of Enzalutamide (Formerly MDV3100) on the Androgen Signaling Pathway in Correlation With the Anti-tumor Effects of Enzalutamide to Identify Potential Predictors of Response or Resistance to Therapy
Condition: Metastatic Progressive Castration-resistant Prostate Cancer
Intervention: Drug: Enzalutamide
32 Terminated An Extension of the HORIZON Protocol Evaluating the Safety of Dimebon (Latrepirdine) in Subjects With Huntington Disease
Condition: Huntington Disease
Intervention: Drug: Dimebon (latrepirdine)
33 Active, not recruiting
Has Results
Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy
Condition: Castration-Resistant Prostate Cancer
Interventions: Drug: Enzalutamide;   Drug: Placebo
34 Terminated A Safety and Efficacy Study Evaluating Dimebon (Latrepirdine) in Patients With Moderate to Severe Alzheimer's Disease
Condition: Moderate to Severe Alzheimer
Interventions: Drug: Dimebon (latrepirdine);   Drug: Placebo
35 Completed A Safety and Efficacy Study of Dimebon in Patients With Huntington Disease
Condition: Huntington Disease
Interventions: Drug: Dimebon;   Other: Placebo
36 Completed Study to Evaluate the Safety, Tolerability and Efficacy of FOLFOX + CT-011 Versus FOLFOX Alone
Condition: Metastatic Colorectal Cancer
Interventions: Drug: CT-011;   Drug: FOLFOX
37 Completed Safety and Tolerability of Dimebon in Patients on Memantine, and Memantine Plus Donepezil
Condition: Alzheimer's Disease
Interventions: Drug: Dimebon;   Drug: Placebo
38 Completed Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on Donepezil
Condition: Alzheimer's Disease
Interventions: Drug: Dimebon;   Drug: Placebo comparator
39 Terminated Study of Combination Therapy With Dimebon and Donepezil (Aricept) in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: dimebon
40 Completed A Study of the Novel Drug Dimebon in Patients With Huntington's Disease
Condition: Huntington's Disease
Interventions: Other: Placebo;   Drug: Dimebon

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.